MX2020013484A - Vacunacion contra circovirus porcinos. - Google Patents

Vacunacion contra circovirus porcinos.

Info

Publication number
MX2020013484A
MX2020013484A MX2020013484A MX2020013484A MX2020013484A MX 2020013484 A MX2020013484 A MX 2020013484A MX 2020013484 A MX2020013484 A MX 2020013484A MX 2020013484 A MX2020013484 A MX 2020013484A MX 2020013484 A MX2020013484 A MX 2020013484A
Authority
MX
Mexico
Prior art keywords
porcine circoviruses
vaccination against
against porcine
pcv
vaccinating
Prior art date
Application number
MX2020013484A
Other languages
English (en)
Inventor
Roman Krejci
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of MX2020013484A publication Critical patent/MX2020013484A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La invención se refiere a composiciones y métodos para tratar o prevenir enfermedades causadas por circovirus porcinos. La invención describe en particular métodos para controlar la infección o enfermedad por PCV en una piara de cerdos, que comprenden (i) vacunar a las cerdas contra PCV en la etapa de destete y (ii) vacunar a los lechones contra PCV a una edad de entre 2 y 7 semanas.
MX2020013484A 2018-06-11 2019-06-10 Vacunacion contra circovirus porcinos. MX2020013484A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18305709 2018-06-11
PCT/EP2019/065081 WO2019238611A1 (en) 2018-06-11 2019-06-10 Vaccination against porcine circoviruses

Publications (1)

Publication Number Publication Date
MX2020013484A true MX2020013484A (es) 2021-05-27

Family

ID=62778842

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020013484A MX2020013484A (es) 2018-06-11 2019-06-10 Vacunacion contra circovirus porcinos.

Country Status (10)

Country Link
US (1) US11918637B2 (es)
EP (1) EP3801609A1 (es)
JP (1) JP2021527073A (es)
KR (1) KR20210019030A (es)
CN (1) CN112292149A (es)
BR (1) BR112020025211A2 (es)
CA (1) CA3102685A1 (es)
MX (1) MX2020013484A (es)
PH (1) PH12020552130A1 (es)
WO (1) WO2019238611A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109588568B (zh) * 2018-12-18 2022-04-08 南京农业大学 一种通过日粮添加原花青素提高母猪繁殖性能的方法
EP3953370A1 (en) 2019-04-04 2022-02-16 Boehringer Ingelheim Animal Health USA Inc. Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1816200B1 (en) 1997-12-11 2016-03-09 Merial Postweaning multisystemic wasting syndrome virus for pigs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
PL2481420T3 (pl) * 2006-12-15 2019-08-30 Boehringer Ingelheim Animal Health USA Inc. Jednodawkowa szczepionka anty-PCV2 dla świń
ME01156B (me) 2007-12-21 2013-03-20 Zoetis Services Llc Postupci i kompozicije za imunizaciju svinja protiv svinjskog cirkovirusa
PL3300690T3 (pl) * 2008-01-31 2019-11-29 Zoetis Services Llc System do szczepienia trzody chlewnej
EA201100862A1 (ru) 2008-11-28 2012-01-30 Сева Санте Анималь Новый изолят свиного цирковируса типа 2b и его применения
TWI508974B (zh) * 2010-12-22 2015-11-21 Sbc Virbac Ltd 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
EP2564869A1 (en) 2011-09-02 2013-03-06 Ceva Sante Animale Synthetic capsid proteins and uses thereof
EP2789346A1 (en) 2013-04-11 2014-10-15 CEVA Santé Animale SA Fusion polypeptides and vaccines
US20140348874A1 (en) * 2013-05-22 2014-11-27 Boehringer Ingelheim Espana, S.A. Method for the reduction of pcv-2 in a herd of swine
BR112016006192A2 (pt) 2013-09-25 2017-09-26 Zoetis Services Llc composição de vacina de divergente de pcv2b e métodos de uso

Also Published As

Publication number Publication date
BR112020025211A2 (pt) 2021-03-09
CN112292149A (zh) 2021-01-29
KR20210019030A (ko) 2021-02-19
CA3102685A1 (en) 2019-12-19
US11918637B2 (en) 2024-03-05
US20210338792A1 (en) 2021-11-04
WO2019238611A1 (en) 2019-12-19
JP2021527073A (ja) 2021-10-11
PH12020552130A1 (en) 2021-07-19
EP3801609A1 (en) 2021-04-14

Similar Documents

Publication Publication Date Title
UA103298C2 (ru) Способ лечения молодых свиней с помощью антигена pcv2
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
ECSP056189A (es) Composiciones y método para el tratamiento de infecciones en ganado vacuno y porcino
PH12020552130A1 (en) Vaccination against porcine circoviruses
TW200744631A (en) Lawsonia vaccine and methods of use thereof
MY152149A (en) Prevention and treatment of sub-clinical pcvd
ECSP056074A (es) Composiciones y método para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
MX2022002056A (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
UA114286C2 (uk) Спосіб лікування staphylococcus aureus
DE602006016005D1 (de) Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren
NZ758609A (en) A solid feed combination composition for ruminant calves
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
MX2022003218A (es) Vacunas para abejas y metodos de uso.
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
Kautz et al. Use of a staphylococcal vaccine to reduce prevalence of mastitis and lower somatic cell counts in a registered Saanen dairy goat herd
MX363264B (es) Vectores de vacuna recombinante de herpesvirus bovino 1 (bohv-1) con baja virulencia.
CL2009000987A1 (es) Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales.
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
Cook A lesion oriented, life cycle approach to preventing lameness in dairy herds
MX2020010243A (es) Composiciones bucales y metodos para animales.
Warner et al. Control of Ornithobacterium rhinotracheale in poultry
RU2020142931A (ru) Вакцинация против цирковирусов свиней
MX2023002625A (es) Composiciones y metodos para proporcionar beneficios para la salud en un animal.
Ramis et al. PCV2 viremia and performance in vaccinated and unvaccinated animals inside a long-term vaccinated herd with Ingelvac CircoFLEX®
UA115040U (xx) Спосіб відбору основних свиноматок для штучного осіменіння